Company research / ACHC

Acadia Healthcare Company, Inc. (ACHC)

CIK 0001520697 · Nasdaq · Services-Specialty Outpatient Facilities, NEC

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Acadia Healthcare Company, Inc. reported revenue of $3.31B. Revenue grew 5.0% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $3.37B.

Key ratios (year ended 2025-12-31)

-33.3%
Net margin
-56.6%
Return on year-end equity
5.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-25

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-03-31
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$3.37B$3.31B$3.15B$2.93B$2.61B$2.31B$2.09B$2.01B$1.90B$2.84B$2.81B
Operating Incomen/an/an/an/an/an/an/a$585.88M$593.58M$604.36M$608.59M
Depreciation & Amortization$194.64M$189.25M$149.59M$132.35M$117.77M$106.72M$95.26M$87.92M$80.34M$143.01M$135.10M
EBITDAn/an/an/an/an/an/an/a$673.81M$673.92M$747.37M$743.69M
Net Income-$1.11B-$1.10B$255.61M-$21.67M$273.14M$190.63M-$672.13M$108.92M-$175.75M$199.84M$6.14M
EPS (Diluted)n/a-$12.16$2.78-$0.24$2.98$2.10-$7.59$1.24-$2.01$2.30$0.07
Total Assets$5.55B$5.53B$5.96B$5.36B$4.99B$4.77B$6.50B$6.88B$6.17B$6.42B$6.02B
Total Liabilities$3.38B$3.39B$2.77B$2.47B$2.09B$2.19B$4.54B$4.34B$3.81B$3.83B$3.84B
Long-Term Debt$2.53B$2.50B$1.96B$1.37B$1.39B$1.50B$3.12B$3.15B$3.19B$3.24B$3.29B
Shareholders' Equity$1.96B$1.95B$3.07B$2.78B$2.81B$2.52B$1.90B$2.51B$2.33B$2.57B$2.17B
Cash & Equivalents$158.47M$133.24M$76.31M$100.07M$97.65M$133.81M$378.70M$99.53M$50.51M$67.29M$57.06M
Operating Cash Flow$181.95M$131.90M$129.69M$462.34M$380.57M$374.48M$658.81M$332.90M$414.08M$399.58M$361.48M
Capital Expenditures$473.74M$571.81M$690.38M$424.13M$296.15M$244.81M$224.96M$232.68M$253.19M$274.18M$307.47M
Free Cash Flow-$291.79M-$439.91M-$560.69M$38.21M$84.42M$129.67M$433.84M$100.22M$160.89M$125.40M$54.01M
Share Repurchasesn/a$50.03Mn/an/an/an/an/an/an/an/an/a
Shares Outstanding90.76M90.45M91.78M91.26M89.91M89.03M88.02M87.72M87.44M87.06M86.69M
Weighted Average Diluted Sharesn/a90.70M92.06M90.95M91.56M90.79M88.59M87.82M87.42M87.06M85.97M
EPS (Basic)n/a-$12.16$2.79-$0.24$3.05$2.15-$7.65$1.24-$2.01$2.30$0.07

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView